Eisai Co., Ltd. announced that its partial label change application to remove chronic sinusitis as an approved indication for egg-white lysozyme preparation Neuzym (lysozyme hydrochloride, “lysozyme”) has been approved by the Japanese Ministry of Health, Labour and Welfare (MHLW). With the approval of the partial label change, Neuzym will no longer able to be used for the indication of “chronic sinusitis.”